RN

Rajesh Nathalal Gokani

Active Director Director DIN 10660237
DIN 10660237 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Nathalal Gokani

Data last updated:

Rajesh Nathalal Gokani is a Director at A.T Joonyar Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10660237
Primary Designation Director
Industry Pharma
First Appointment 07 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jun 20242024Active

Directorship timeline

Open interactive timeline →
A.T Joonyar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Nathalal Gokani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Nathalal Gokani

Rajesh Nathalal Gokani currently holds 1 directorship: A.T Joonyar Pharmaceuticals Private Limited (Director, since 07 Jun 2024).

Rajesh Nathalal Gokani was first appointed on 07 Jun 2024 as Director at A.T Joonyar Pharmaceuticals Private Limited.

The current boards of Rajesh Nathalal Gokani's companies include Milan Arvindbhai Dadhania (A.T Joonyar Pharmaceuticals Private Limited), Rajesh Bhailal Adeshra (A.T Joonyar Pharmaceuticals Private Limited), Urun Rajeshbhai Gokani (A.T Joonyar Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available